DRDR.L vs. MOAT.L
DRDR.L (iShares Healthcare Innovation UCITS ETF USD (Acc)) and MOAT.L (VanEck Morningstar US Sustainable Wide Moat UCITS ETF) are both exchange-traded funds - DRDR.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while MOAT.L is a Large Cap Blend Equities fund tracking the Russell 1000 TR USD. Both are passively managed. Over the past 5 years, DRDR.L returned -0.91%/yr vs 4.30%/yr for MOAT.L. A 0.67 correlation means they provide meaningful diversification when combined. DRDR.L charges 0.40%/yr vs 0.49%/yr for MOAT.L.
Performance
DRDR.L vs. MOAT.L - Performance Comparison
Loading charts...
Different Trading Currencies
DRDR.L is traded in GBp, while MOAT.L is traded in USD. To make them comparable, the MOAT.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, DRDR.L achieves a 1.01% return, which is significantly higher than MOAT.L's -2.27% return.
DRDR.L
- 1D
- 3.48%
- 1M
- 6.16%
- YTD
- 1.01%
- 6M
- -0.48%
- 1Y
- 21.74%
- 3Y*
- 3.43%
- 5Y*
- -0.91%
- 10Y*
- —
MOAT.L
- 1D
- 1.08%
- 1M
- 4.43%
- YTD
- -2.27%
- 6M
- -3.00%
- 1Y
- 9.41%
- 3Y*
- 5.44%
- 5Y*
- 4.30%
- 10Y*
- 11.37%
DRDR.L vs. MOAT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DRDR.L iShares Healthcare Innovation UCITS ETF USD (Acc) | 1.01% | 10.25% | 2.62% | -2.51% | -14.93% | -5.21% | 48.69% | 8.88% | 2.12% | 23.69% |
MOAT.L VanEck Morningstar US Sustainable Wide Moat UCITS ETF | -2.27% | -0.31% | 13.06% | 12.45% | -9.03% | 26.72% | 10.28% | 28.71% | 3.71% | 12.41% |
Correlation
The correlation between DRDR.L and MOAT.L is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.69 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.69 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2016 | 0.67 |
The correlation between DRDR.L and MOAT.L has been stable across timeframes, ranging from 0.67 to 0.69 - a consistent structural relationship.
DRDR.L vs. MOAT.L - Sectors Allocation Comparison
Sectors
DRDR.L
MOAT.L
Healthcare
Technology
Industrials
Basic Materials
Financial Services
Consumer Defensive
Communication Services
-
Consumer Cyclical
-
Energy
-
-
Real Estate
-
Utilities
-
-
Healthcare
DRDR.L
MOAT.L
Technology
DRDR.L
MOAT.L
Industrials
DRDR.L
MOAT.L
Basic Materials
DRDR.L
MOAT.L
Financial Services
DRDR.L
MOAT.L
Consumer Defensive
DRDR.L
MOAT.L
Communication Services
DRDR.L
-
MOAT.L
Consumer Cyclical
DRDR.L
-
MOAT.L
Energy
DRDR.L
-
MOAT.L
-
Real Estate
DRDR.L
-
MOAT.L
Utilities
DRDR.L
-
MOAT.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DRDR.L vs. MOAT.L — Risk / Return Rank
DRDR.L
MOAT.L
DRDR.L vs. MOAT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) and VanEck Morningstar US Sustainable Wide Moat UCITS ETF (MOAT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DRDR.L | MOAT.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.70 | ||
| Sortino ratioReturn per unit of downside risk | +0.97 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.13 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 1.73 | 0.86 | +0.87 |
| Martin ratioReturn relative to average drawdown | 4.35 | 2.03 | +2.32 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DRDR.L | MOAT.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.39 | 0.69 | +0.70 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.28 | -0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.67 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.34 | 0.73 | -0.39 |
Drawdowns
DRDR.L vs. MOAT.L - Drawdown Comparison
The maximum DRDR.L drawdown since its inception was -38.49%, which is greater than MOAT.L's maximum drawdown of -25.07%. Use the drawdown chart below to compare losses from any high point for DRDR.L and MOAT.L.
Loading charts...
Drawdown Indicators
| DRDR.L | MOAT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.49% | -25.07% | -13.42% |
Max Drawdown (1Y)Largest decline over 1 year | -12.51% | -10.93% | -1.58% |
Max Drawdown (3Y)Largest decline over 3 years | -22.38% | -23.01% | +0.63% |
Max Drawdown (5Y)Largest decline over 5 years | -35.81% | -23.01% | -12.80% |
Max Drawdown (10Y)Largest decline over 10 years | — | -25.07% | — |
Current DrawdownCurrent decline from peak | -16.88% | -6.67% | -10.21% |
Average DrawdownAverage peak-to-trough decline | -15.17% | -4.46% | -10.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.98% | 4.62% | +0.36% |
Volatility
DRDR.L vs. MOAT.L - Volatility Comparison
iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) has a higher volatility of 4.79% compared to VanEck Morningstar US Sustainable Wide Moat UCITS ETF (MOAT.L) at 3.72%. This indicates that DRDR.L's price experiences larger fluctuations and is considered to be riskier than MOAT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DRDR.L | MOAT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.79% | 3.72% | +1.07% |
Volatility (6M)Calculated over the trailing 6-month period | 11.52% | 9.68% | +1.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.56% | 13.50% | +2.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.52% | 15.60% | +1.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.58% | 16.94% | +1.64% |
DRDR.L vs. MOAT.L - Expense Ratio Comparison
DRDR.L has a 0.40% expense ratio, which is lower than MOAT.L's 0.49% expense ratio.
Dividends
DRDR.L vs. MOAT.L - Dividend Comparison
Neither DRDR.L nor MOAT.L has paid dividends to shareholders.
Frequently Asked Questions
DRDR.L and MOAT.L have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, DRDR.L is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
DRDR.L is cheaper with a 0.40% expense ratio, compared with 0.49% for MOAT.L.
DRDR.L is categorized as Health & Biotech Equities, while MOAT.L is Large Cap Blend Equities. DRDR.L tracks MSCI World/Health Care NR USD, while MOAT.L tracks Russell 1000 TR USD. They also come from different issuers: iShares and VanEck. Their fees differ too: 0.40% for DRDR.L and 0.49% for MOAT.L.
Find the right allocation for DRDR.L and MOAT.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer